supp.fit

Artemisinin: study protocols

20 study groups say how much Artemisinin participants took a day. These are the doses the studies gave. They are not a recommendation.

Artemisinin: what the research found →

Dose per serving from products

40 products in our catalogue print how much Artemisinin a serving holds.

Most common: 100 mg to 250 mg, 53% of 40 products.

Dose per servingProducts
10 mg to 25 mg
3
25 mg to 50 mg
1
50 mg to 100 mg
9
100 mg to 250 mg
21
250 mg to 500 mg
2
500 mg to 1 g
4

Dose per serving from research

11 study groups in 8 studies say how much Artemisinin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 mg/kg to 5 mg/kg, 45% of 11 study groups.

Daily doseStudy groups
1 mg/kg to 2.5 mg/kg
4
2.5 mg/kg to 5 mg/kg
5
5 mg/kg to 10 mg/kg
1
10 mg/kg to 25 mg/kg
1

Commonly used together

17 of 20 study groups took Artemisinin with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
amodiaquine
4
piperaquine
4

20 study groups

Study
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda
2005 · AQ + AS · Patients aged 6 months or older with uncomplicated Plasmodium falciparum malaria; both sexes, not pregnant
4 mg/kg3 days731
Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial
2020 · PZQ+DHP · School-going children aged 7–17 years with Schistosoma mansoni intestinal schistosomiasis in rural Tanzania
40 mg3 days298
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania
2007 · AS+AQ (Mlimba site) · Children aged 6–59 months with uncomplicated Plasmodium falciparum malaria
4 mg/kg3 days76
A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial
2011 · DHAPQ · Children aged 6–59 months with uncomplicated Plasmodium falciparum malaria (12–59 months at sites using CD+A)
2.25 mg/kg3 days1,475
A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial
2011 · ASAQ · Children aged 6–59 months with uncomplicated Plasmodium falciparum malaria (12–59 months at sites using CD+A)
2.8 mg/kg3 days1,002
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
2010 · DHA/PQP · Males and females aged 3 months to 65 years with uncomplicated, microscopically confirmed falciparum or mixed malaria; Indian participants were aged 18 years or older
2.25 mg/kg3 days767
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
2019 · DHA-PQ group · Children aged 2.33–58.1 months in Burkina Faso, apparently healthy and living in an area of intense seasonal malaria transmission
2 mg/kg90 days754
A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages
2018 · Intervention (early MDA) · Residents of four Cambodian forest-fringe villages; all ages except infants under 6 months, pregnant or lactating women, and people with acute health problems
7 mg/kg90 days668
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial
2015 · Intermittent preventive treatment with dihydroartemisinin–piperaquine · HIV-negative pregnant women, 16–32 weeks’ gestation, without a stated diagnosis.
80 mg—516
Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial
2009 · AS-SMP 3 days · People aged over 6 months with uncomplicated P. falciparum malaria; both sexes; pregnant people excluded
200 mg3 days476